Risk Factors for Long-Term Vancomycin-Resistant Enterococci Persistence—A Prospective Longitudinal Study
暂无分享,去创建一个
A. Mellmann | F. Schaumburg | A. Kossow | C. Correa-Martínez | S. Kampmeier | V. B. Stollenwerk | V. Stollenwerk
[1] P. Zachariah,et al. Vancomycin use in surrounding patients during critical illness and risk for persistent colonization with vancomycin-resistant Enterococcus. , 2019, The Journal of hospital infection.
[2] Ronald N. Jones,et al. Temporal and Geographic Variation in Antimicrobial Susceptibility and Resistance Patterns of Enterococci: Results From the SENTRY Antimicrobial Surveillance Program, 1997–2016 , 2019, Open forum infectious diseases.
[3] Kerri A. Thom,et al. Bacterial burden is associated with increased transmission to health care workers from patients colonized with vancomycin‐resistant Enterococcus , 2019, American journal of infection control.
[4] P. Zachariah,et al. The local hospital milieu and healthcare-associated vancomycin-resistant enterococcus acquisition. , 2019, The Journal of hospital infection.
[5] Krinko,et al. Hygienemaßnahmen zur Prävention der Infektion durch Enterokokken mit speziellen Antibiotikaresistenzen , 2018, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.
[6] A. Mellmann,et al. Hospital acquired vancomycin resistant enterococci in surgical intensive care patients – a prospective longitudinal study , 2018, Antimicrobial Resistance & Infection Control.
[7] D. Elashoff,et al. Noninfectious Hospital Adverse Events Decline After Elimination of Contact Precautions for MRSA and VRE , 2018, Infection Control & Hospital Epidemiology.
[8] G. Alangaden,et al. The Role of Environmental Contamination in the Transmission of Nosocomial Pathogens and Healthcare-Associated Infections , 2018, Current Infectious Disease Reports.
[9] P. Gastmeier,et al. Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany − 10 years of surveillance , 2018, Antimicrobial Resistance & Infection Control.
[10] M. Ouellette,et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. , 2017, The Lancet. Infectious diseases.
[11] T. Eckmanns,et al. Eigenschaften, Häufigkeit und Verbreitung von VancomycinresistentenEnterokokken (VRE) in Deutschland , 2017 .
[12] P. Gastmeier,et al. The effect of antibiotic use on prevalence of nosocomial vancomycin-resistant enterococci- an ecologic study , 2017, Antimicrobial Resistance & Infection Control.
[13] David Baur,et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. , 2017, The Lancet. Infectious diseases.
[14] A. Hendrickx,et al. Multidrug-Resistant Enterococcal Infections: New Compounds, Novel Antimicrobial Therapies? , 2017, Trends in microbiology.
[15] H. Rohde,et al. Screening and contact precautions – A survey on infection control measures for multidrug-resistant bacteria in German university hospitals , 2017, Antimicrobial Resistance & Infection Control.
[16] E. Larson,et al. Temporal trends and risk factors for healthcare-associated vancomycin-resistant enterococci in adults. , 2016, The Journal of hospital infection.
[17] F. Petersen,et al. Room contamination, patient colonization pressure, and the risk of vancomycin-resistant Enterococcus colonization on a unit dedicated to the treatment of hematologic malignancies and hematopoietic stem cell transplantation. , 2016, American journal of infection control.
[18] A. Mellmann,et al. Real-Time Genome Sequencing of Resistant Bacteria Provides Precision Infection Control in an Institutional Setting , 2016, Journal of Clinical Microbiology.
[19] J. Haldar,et al. A Vancomycin Derivative with a Pyrophosphate-Binding Group: A Strategy to Combat Vancomycin-Resistant Bacteria. , 2016, Angewandte Chemie.
[20] N. Ledeboer,et al. Resistance Mechanisms, Epidemiology, and Approaches to Screening for Vancomycin-Resistant Enterococcus in the Health Care Setting , 2016, Journal of Clinical Microbiology.
[21] P. Brindley,et al. Patient Isolation Precautions: Are They Worth It? , 2016, Canadian respiratory journal.
[22] F. Román,et al. Horizontal gene transmission of the cfr gene to MRSA and Enterococcus: role of Staphylococcus epidermidis as a reservoir and alternative pathway for the spread of linezolid resistance. , 2016, The Journal of antimicrobial chemotherapy.
[23] Malbert R. C. Rogers,et al. Core Genome Multilocus Sequence Typing Scheme for High-Resolution Typing of Enterococcus faecium , 2015, Journal of Clinical Microbiology.
[24] M. Juhas. Horizontal gene transfer in human pathogens , 2015, Critical reviews in microbiology.
[25] J. Burke,et al. Frequency, Risk Factors, and Outcomes of Vancomycin-Resistant Enterococcus Colonization and Infection in Patients with Newly Diagnosed Acute Leukemia: Different Patterns in Patients with Acute Myelogenous and Acute Lymphoblastic Leukemia , 2015, Infection Control & Hospital Epidemiology.
[26] E. Petinaki,et al. Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients , 2014, Infection.
[27] R. Chemaly,et al. The role of the healthcare environment in the spread of multidrug-resistant organisms: update on current best practices for containment , 2014, Therapeutic advances in infectious disease.
[28] C. Ruscher. Empfehlungen zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in medizinischen und pflegerischen Einrichtungen , 2014, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.
[29] Y. Carmeli,et al. Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis. , 2014, The Journal of antimicrobial chemotherapy.
[30] R. Walensky,et al. Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review , 2014, BMC Infectious Diseases.
[31] K. Peck,et al. Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[32] Yee-Chun Chen,et al. Incidence of and Risk Factors for Infection or Colonization of Vancomycin-Resistant Enterococci in Patients in the Intensive Care Unit , 2012, PloS one.
[33] gramnegativen Stäbchen. Hygienemaßnahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen Stäbchen , 2012, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.
[34] M. Ott,et al. Vancomycin-resistant enterococci (VRE) and the role of the healthcare worker. , 2008, Canadian operating room nursing journal.
[35] F. Baquero,et al. Global Spread of Vancomycin-resistant Enterococcus faecium from Distinct Nosocomial Genetic Complex , 2005, Emerging infectious diseases.
[36] Y. Carmeli,et al. Antecedent Treatment with Different Antibiotic Agents as a Risk Factor for Vancomycin-Resistant Enterococcus , 2002, Emerging infectious diseases.
[37] G. Eliopoulos,et al. Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance". , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[38] J. Patterson,et al. Antibiotic utilization: is there an effect on antimicrobial resistance? , 2001, Chest.
[39] R. Wiesner,et al. Natural history of vancomycin‐resistant enterococcal colonization in liver and kidney transplant recipients , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[40] A. Ambergen,et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. , 1998, Archives of internal medicine.
[41] J. Duval,et al. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. , 1988, The New England journal of medicine.
[42] N. Woodford,et al. VANCOMYCIN-RESISTANT ENTEROCOCCI , 1988, The Lancet.
[43] L. Rice,et al. Vancomycin-resistant enterococci colonization among dialysis patients: a meta-analysis of prevalence, risk factors, and significance. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[44] W. Schaffner,et al. MAJOR ARTICLE: Vancomycin‐Resistant Enterococci among Chronic Hemodialysis Patients: A Prospective Study of Acquisition , 2001 .
[45] D. Fleming,et al. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). , 1995, American journal of infection control.